Linzess 72 MCG capsule UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJW56
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,385
Award facts
- Contract value 100% obligated
- $10,384.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 capsules of Linzess 72 MCG, a medication used to treat irritable bowel syndrome and chronic idiopathic constipation. This $10,384.80 firm fixed price delivery order, awarded on September 10, 2025, with completion expected by September 11, 2025, represents a non-competitive set-aside contract fulfilling federal pharmaceutical supply needs. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor serving the Defense Health Agency and other federal healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad spectrum of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. As a prime vendor for the DLA Medical Supply Chain, AmerisourceBergen has established itself as a critical supplier through competitively awarded contracts demonstrating its capability to efficiently fulfill federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJW56?
SPE2DB25FJW56 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FJW56 worth?
The government has obligated $10,385 on SPE2DB25FJW56.
Is contract SPE2DB25FJW56 an order under another contract?
Yes. SPE2DB25FJW56 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJW56 competed?
The extent of competition for SPE2DB25FJW56 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award